What is Docetaxel-trastuzumab-pertuzumab (DHP)?

Category: Prescription Drugs


See also: Docetaxel Pertuzumab Trastuzumab

Docetaxel-trastuzumab-pertuzumab, also known as DHP, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents docetaxel (Taxotere®), trastuzumab (Herceptin®), and pertuzumab (Perjeta®).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 2
Mild 0
None 0

Commonly reported side effects and conditions associated with Docetaxel-trastuzumab-pertuzumab (DHP)

Side effect Patients
Fatigue 1
Pain 1
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1
Last updated:
There are no evaluations for Docetaxel-trastuzumab-pertuzumab (DHP).